Juvenile idiopathic arthritis. (I) Clinical aspects;Arthrites juvéniles idiopathiques I. Les différentes formes cliniques

Revue du Praticien

Volumn 57, Issue 11, 2007, Pages 1171-1178

  Quartier, Pierre ^b   Prieur, Anne Marie ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MORBIDITY; PROGNOSIS; RADIOGRAPHY; REVIEW; UVEITIS;

ADOLESCENT; ADULT; AGE FACTORS; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FRANCE; HUMANS; INCIDENCE; PROGNOSIS; TIME FACTORS;

EID: 34347402467     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (5)

1. Petty RE, Southwood TR, Baum J, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 1998;25:1991-4.
2. Prieur AM, Le Gall E, Karman F, Edan C, et al. Epidemiologic survey of juvenile chronic arthritis in France. Comparison of data obtained from two different regions. Clin Exp Rheumatol 1987;5:217-23.
3. Hofer MF, Mouy R, Prieur AM. Juvenile idiopathic arthritides evaluated prospectively in a single center according to the Durban criteria. J Rheumatol 2001;28:1083-90.
4. Woo P, Southwood TR, Prieur AM, et al. Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis. Arthritis Rheum 2000;43:1849-57.
5. Quartier P, Taupin P, Bourdeaut F, et al. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis Rheum 2003;48:1093-101.